Data Set for Reporting of Endometrial Carcinomas: Recommendations From the International Collaboration on Cancer Reporting (ICCR) Between United Kingdom, United States, Canada, and Australasia

The International Collaboration on Cancer Reporting is a quadripartite alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, and the Canadian Partnership Against Cancer. The International Collaboration on Cancer Reporting was formed with a view to reducing the global burden of cancer data set development and reduplication of the effort by different international institutions that commission, publish, and maintain standardized cancer-reporting data sets. The resultant standardization of cancer reporting would be expected to benefit not only those countries directly involved in the collaboration, but also others not in a position to develop their own data sets. The main objective of the International Collaboration on Cancer Reporting is to develop an evidence-based–reporting data set for each cancer site, and to this end, a project to develop data sets for prostate, endometrium, and lung cancers and malignant melanoma was piloted by the quadripartite group. This review describes the process of development of the endometrial cancer data set.

[1]  C Blake Gilks,et al.  Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance , 2011, Histopathology.

[2]  H. Boezen,et al.  Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component , 2011, Modern Pathology.

[3]  K. Chao,et al.  The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. , 2011, Gynecologic oncology.

[4]  E. Oliva,et al.  Significant Variation in the Assessment of Cervical Involvement in Endometrial Carcinoma: An Interobserver Variation Study , 2011, The American journal of surgical pathology.

[5]  B. Clarke,et al.  Histologic Artifacts in Abdominal, Vaginal, Laparoscopic, and Robotic Hysterectomy Specimens: A Blinded, Retrospective Review , 2011, The American journal of surgical pathology.

[6]  F. Gao,et al.  Lower Uterine Segment Involvement is Associated with Poor Outcomes in Early-Stage Endometrioid Endometrial Carcinoma , 2011, Annals of Surgical Oncology.

[7]  Ruchira Singh,et al.  BMI and Uterine Size: Is There Any Relationship? , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  M. Stoler,et al.  Cervical Stromal Invasion Predicting Survival in Endometrial Cancer , 2010, Obstetrics and gynecology.

[9]  S. Kehoe,et al.  Which Staging System to Use for Gynecological Cancers: Recommendations for Practice in the United Kingdom , 2010, International Journal of Gynecologic Cancer.

[10]  M. Stoler,et al.  The Significance of Tumor Involved Adenomyosis in Otherwise Low-stage Endometrioid Adenocarcinoma , 2010, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  S. Kehoe,et al.  Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK , 2010, Journal of Clinical Pathology.

[12]  A. Obermair,et al.  Evaluation of Tumor-Free Distance and Depth of Myometrial Invasion as Prognostic Factors for Lymph Node Metastases in Endometrial Cancer , 2010, International Journal of Gynecologic Cancer.

[13]  W. McCluggage,et al.  Mullerian Adenosarcoma of the Female Genital Tract , 2010, Advances in anatomic pathology.

[14]  Seyed Shahabeddin Sadr,et al.  Study of the normal internal organ weights in Tehran's population. , 2010, Journal of forensic and legal medicine.

[15]  S. Pecorelli Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .

[16]  W. McCluggage Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens , 2009 .

[17]  C. Gilks,et al.  Protocol for the Examination of Specimens From Patients With Carcinoma of the Endometrium , 2009 .

[18]  W. McCluggage,et al.  WT1, p53 and hormone receptor expression in uterine serous carcinoma , 2009, Histopathology.

[19]  I. Shih,et al.  Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas: Immunohistochemical Analysis of 201 Cases , 2009, The American journal of surgical pathology.

[20]  E. Anteby,et al.  Lower uterine segment involvement is associated with adverse outcome in patients with stage I endometroid endometrial cancer: results of a multicenter study. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  A. Secord,et al.  Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. , 2009, Gynecologic oncology.

[22]  K. Garg,et al.  Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma , 2009, Journal of Clinical Pathology.

[23]  Rebecca Tooher,et al.  Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence' , 2009, BMC medical research methodology.

[24]  E. Oliva,et al.  Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. , 2009, Gynecologic oncology.

[25]  K. Kosarin,et al.  Selection of Endometrial Carcinomas for DNA Mismatch Repair Protein Immunohistochemistry Using Patient Age and Tumor Morphology Enhances Detection of Mismatch Repair Abnormalities , 2009, The American journal of surgical pathology.

[26]  E. Myers,et al.  Cost effectiveness of a test to detect metastases for endometrial cancer. , 2009, Gynecologic oncology.

[27]  A. Malpica,et al.  Vascular Pseudoinvasion in Laparoscopic Hysterectomy Specimens for Endometrial Carcinoma: A Grossing Artifact? , 2009, The American journal of surgical pathology.

[28]  L. Akslen,et al.  Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma , 2009, Histopathology.

[29]  D. Cohn,et al.  Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. , 2009, Gynecologic oncology.

[30]  R. Soslow,et al.  Application of immunohistochemistry to gynecologic pathology. , 2009, Archives of pathology & laboratory medicine.

[31]  D. Bodurka,et al.  Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Gammerman,et al.  Predicting Clinical Outcome in Patients Diagnosed with Synchronous Ovarian and Endometrial Cancer , 2008, Clinical Cancer Research.

[33]  James V. Little,et al.  Vascular “Pseudo Invasion” in Laparoscopic Hysterectomy Specimens: A Diagnostic Pitfall , 2008, The American journal of surgical pathology.

[34]  O. Fadare,et al.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers , 2008, Diagnostic pathology.

[35]  Wenxin Zheng,et al.  Endometrial glandular dysplasia and endometrial intraepithelial neoplasia , 2008, Current opinion in obstetrics & gynecology.

[36]  M. Deveci,et al.  Does the localisation of tumour at stage I endometrial endometrioid adenocarcinoma have an impact on invasion of the tumour and individualisation of the surgical procedure? , 2008, European journal of gynaecological oncology.

[37]  R. Barakat,et al.  Prognostic Features of Surgical Stage I Uterine Carcinosarcoma , 2007, The American journal of surgical pathology.

[38]  Richard G. Moore,et al.  Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma. , 2007, Gynecologic oncology.

[39]  J. Berek,et al.  Lymphadenectomy in endometrioid uterine cancer staging , 2007, Cancer.

[40]  A. Evans,et al.  Peritoneal keratin granulomas complicating endometrial carcinoma: a report of two cases and review of the literature , 2007, International Journal of Gynecologic Cancer.

[41]  R. Soslow,et al.  Difficulties in Assessing the Depth of Myometrial Invasion in Endometrial Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[42]  P. Disaia,et al.  Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. , 2007, Gynecologic oncology.

[43]  Y. Saga,et al.  Omental metastases in clinical stage I endometrioid adenocarcinoma , 2007, International Journal of Gynecologic Cancer.

[44]  A. Malpica,et al.  Undifferentiated carcinoma of the endometrium: a review. , 2007, Pathology.

[45]  J. Davis,et al.  Occurrence of Endometrial Glandular Dysplasia Precedes Uterine Papillary Serous Carcinoma , 2007, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[46]  E. Hauth,et al.  MR imaging of the uterus and cervix in healthy women: Determination of normal values , 2007, European Radiology.

[47]  A. Berchuck,et al.  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. , 2006, Gynecologic oncology.

[48]  A. Malpica,et al.  Endometrioid Carcinoma Simultaneously Involving the Uterus and the Fallopian Tube: A Clinicopathologic Study of 13 Cases , 2006, The American journal of surgical pathology.

[49]  T. Lesnick,et al.  Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. , 2006, Gynecologic oncology.

[50]  D. Aoki,et al.  Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer , 2005, International Journal of Gynecologic Cancer.

[51]  S. Mount,et al.  Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. , 2006, Gynecologic oncology.

[52]  P. Maisonneuve,et al.  Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[53]  C. Powell Occult ovarian cancer at the time of risk-reducing salpingo-oophorectomy. , 2006, Gynecologic oncology.

[54]  D. Faratian,et al.  A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome , 2005, International Journal of Gynecologic Cancer.

[55]  S. Kalloger,et al.  Description of a Novel System for Grading of Endometrial Carcinoma and Comparison With Existing Grading Systems , 2005, The American journal of surgical pathology.

[56]  R. Walker,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2005 .

[57]  J. McKenney,et al.  Endometrial Adenocarcinoma Associated With Subtle Lymph-Vascular Space Invasion and Lymph Node Metastasis: A Histologic Pattern Mimicking Intravascular and Sinusoidal Histiocytes , 2005, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[58]  I. Jacobs,et al.  A molecular genetic and statistical approach for the diagnosis of dual-site cancers. , 2004, Journal of the National Cancer Institute.

[59]  H. Verkooijen,et al.  Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis , 2004, British Journal of Cancer.

[60]  Jaime Prat,et al.  Prognostic parameters of endometrial carcinoma. , 2004, Human pathology.

[61]  L. Akslen,et al.  Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type , 2004, Histopathology.

[62]  W. McCluggage,et al.  A Critical Appraisal of the Value of Immunohistochemistry in Diagnosis of Uterine Neoplasms , 2004, Advances in anatomic pathology.

[63]  Paul J. L. Zhang,et al.  WT1 is Differentially Expressed in Serous, Endometrioid, Clear Cell, and Mucinous Carcinomas of the Peritoneum, Fallopian Tube, Ovary, and Endometrium , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[64]  A. Ayhan,et al.  The long-term survival of women with surgical stage II endometrioid type endometrial cancer. , 2004, Gynecologic oncology.

[65]  S. de Blok,et al.  Does diagnostic hysteroscopy in patients with stage I endometrial carcinoma cause positive peritoneal washings? , 2004, Gynecologic oncology.

[66]  W. McCluggage WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[67]  W. van Putten,et al.  Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma , 2004, Cancer.

[68]  W. McCluggage,et al.  WT‐1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma , 2004, Histopathology.

[69]  P. Clement,et al.  Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic Aspects , 2002, Advances in anatomic pathology.

[70]  N. Ramirez,et al.  Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer? , 2003, Gynecologic oncology.

[71]  R. Scully,et al.  Unusual Epithelial and Stromal Changes in Myoinvasive Endometrioid Adenocarcinoma: A Study of Their Frequency, Associated Diagnostic Problems, and Prognostic Significance , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[72]  S. Murata,et al.  Wilms Tumor Gene Immunoreactivity in Primary Serous Carcinomas of the Fallopian Tube, Ovary, Endometrium, and Peritoneum , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[73]  V. Sumathi,et al.  Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. , 2003, Human pathology.

[74]  M. J. Webb,et al.  Endometrial cancer: predictors of peritoneal failure. , 2003, Gynecologic oncology.

[75]  T. Kasamatsu,et al.  Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus , 2003, British Journal of Cancer.

[76]  J. Seidman,et al.  Evaluation of the Relationship Between Adenosarcoma and Carcinosarcoma and a Hypothesis of the Histogenesis of Uterine Sarcomas , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[77]  H. Kuramoto,et al.  Parametrial spread is a prognostic factor in endometrial carcinoma. , 2003, European journal of gynaecological oncology.

[78]  H. Hollema,et al.  Vulvar carcinoma , 2002, Cancer.

[79]  A. Obermair,et al.  The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. , 2002, Gynecologic oncology.

[80]  W. McCluggage,et al.  Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas , 2002, International Journal of Gynecologic Cancer.

[81]  G. Lockwood,et al.  Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients. , 2002, International journal of radiation oncology, biology, physics.

[82]  X. Matías-Guiu,et al.  Clonality Analysis in Synchronous or Metachronous Tumors of the Female Genital Tract , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[83]  P. Clement,et al.  Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic Aspects , 2002, Advances in anatomic pathology.

[84]  W. McCluggage,et al.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? , 2002, Journal of clinical pathology.

[85]  N. Goldstein,et al.  WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. , 2002, American journal of clinical pathology.

[86]  L. Jordan,et al.  Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma , 2002, International Journal of Gynecologic Cancer.

[87]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[88]  S. Altunyurt,et al.  Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma , 2001, International Journal of Gynecologic Cancer.

[89]  G. Moreno-Bueno,et al.  &bgr;-Catenin Expression Pattern, &bgr;-Catenin Gene Mutations, and Microsatellite Instability in Endometrioid Ovarian Carcinomas and Synchronous Endometrial Carcinomas , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[90]  A. García,et al.  Molecular pathology of endometrial hyperplasia and carcinoma. , 2001, Human pathology.

[91]  R. Barakat,et al.  High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. , 2001, Gynecologic oncology.

[92]  B. Gilks,et al.  Early stage uterine papillary serous carcinoma of the endometrium , 2001, Cancer.

[93]  S. Sekiya,et al.  Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. , 2001, Cancer.

[94]  J. van der Palen,et al.  Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma , 2000, International Journal of Gynecologic Cancer.

[95]  R. A’Hern,et al.  An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium. , 2000, British Journal of Radiology.

[96]  R. Kurman,et al.  A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma Has Superior Reproducibility Compared With FIGO Grading and Identifies Subsets of Advance-Stage Tumors With Favorable and Unfavorable Prognosis , 2000, The American journal of surgical pathology.

[97]  R. Petersen,et al.  Stage 3B adenocarcinoma of the endometrium: a clinicopathologic study. , 2000, Gynecologic oncology.

[98]  M. Sherman,et al.  Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. , 2000, The American journal of surgical pathology.

[99]  P. Disaia,et al.  Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. , 1999, American journal of obstetrics and gynecology.

[100]  D. O'connor,et al.  An analysis of two versus three grades for endometrial carcinoma. , 1999, Gynecologic oncology.

[101]  G. Eltabbakh,et al.  Survival of women with surgical stage II endometrial cancer. , 1999, Gynecologic oncology.

[102]  A. Mundt,et al.  The significance of adnexal involvement in endometrial carcinoma. , 1999, Gynecologic oncology.

[103]  T. Kaku,et al.  Predicting pelvic lymph node metastasis in endometrial carcinoma. , 1999, Gynecologic oncology.

[104]  M. Hendrickson,et al.  Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. , 1999, The American journal of surgical pathology.

[105]  N. Katsumata,et al.  Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer. , 1998, Japanese journal of clinical oncology.

[106]  R. Kurman,et al.  Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. , 1998, Human pathology.

[107]  K. Shroyer,et al.  Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. , 1997, Cancer research.

[108]  I. Konishi,et al.  Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. , 1996, Gynecologic oncology.

[109]  A. Behrens,et al.  Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. , 1996, Journal of the National Cancer Institute.

[110]  K. Shroyer,et al.  Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. , 1996, American journal of clinical pathology.

[111]  S. Wellek,et al.  Sonographic size of uterus and ovaries in pre‐ and postmenopausal women , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[112]  H. Hoshiai,et al.  The prognostic significance of vascular invasion by endometrial carcinoma. , 1996, Cancer.

[113]  M. Sherman,et al.  Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. , 1995, Human pathology.

[114]  M. Pieretti,et al.  Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium , 1995, Cancer.

[115]  F. Kate,et al.  Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival , 1995, Cancer.

[116]  W. R. Hart,et al.  Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. , 1995, The American journal of surgical pathology.

[117]  M. Carcangiu,et al.  Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[118]  R. Kurman,et al.  The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A gynecologic oncology group study , 1995, Cancer.

[119]  T. Kaku,et al.  Reassessment of Myometrial Invasion in Endometrial Carcinoma , 1994, Obstetrics and gynecology.

[120]  P. Hantschmann,et al.  Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma , 1994, Cancer.

[121]  T. Frank,et al.  Synchronous dual primary ovarian and endometrial carcinomas , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[122]  A. Ayhan,et al.  Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases) , 1993, International Journal of Gynecologic Cancer.

[123]  K. Barwick,et al.  Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. , 1993, Gynecologic oncology.

[124]  R. Woolas,et al.  Mixed serous—endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinoma , 1993, International Journal of Gynecologic Cancer.

[125]  H. Homesley,et al.  Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. , 1992, Gynecologic oncology.

[126]  A. Ayhan,et al.  Synchronous primary malignancies of the female genital tract. , 1992, European journal of obstetrics, gynecology, and reproductive biology.

[127]  M. Sherman,et al.  Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features , 1992, The American journal of surgical pathology.

[128]  M. Sideri,et al.  Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. , 1992, Gynecologic oncology.

[129]  J. Berek,et al.  Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. , 1992, Gynecologic oncology.

[130]  C. Morrow,et al.  Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study , 1991, Gynecologic oncology.

[131]  X. Matías-Guiu,et al.  Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases , 1991, Cancer.

[132]  D. Gal,et al.  Lymphvascular space involvement--a prognostic indicator in endometrial adenocarcinoma. , 1991, Gynecologic oncology.

[133]  M. Piver,et al.  Prognostic significance of the extent of cervical involvement by endometrial cancer. , 1991, Gynecologic oncology.

[134]  D. Herbold,et al.  The significance of squamous differentiation in endometrial carcinoma , 1988 .

[135]  J. Heaps,et al.  Surgical‐pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva , 1991, Gynecologic oncology.

[136]  M. Tompkins,et al.  Prognostic value of peritoneal cytology in endometrial carcinoma , 1990, Gynecologic oncology.

[137]  W. Lawrence,et al.  Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases. , 1990, Gynecologic oncology.

[138]  H. Tilly,et al.  Effect of chemotherapy on resting energy expenditure in patients with non‐Hodgkin's lymphoma results of a sequential study , 1990, Cancer.

[139]  E. Silva,et al.  Serous carcinoma in endometrial polyps. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[140]  P. O'Brien,et al.  Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. , 1990, American journal of obstetrics and gynecology.

[141]  N. Sneige,et al.  The Prognostic Significance of Peritoneal Cytology for Stage I Endometrial Cancer , 1989, Obstetrics and gynecology.

[142]  W. Lichtenegger,et al.  10 Operative anatomy and technique of radical parametrial resection in the surgical treatment of cervical cancer , 1988 .

[143]  W. Lichtenegger,et al.  Operative anatomy and technique of radical parametrial resection in the surgical treatment of cervical cancer. , 1988, Bailliere's clinical obstetrics and gynaecology.

[144]  M. Melhem,et al.  Mucinous Adenocarcinoma of the Endometrium: A Clinico-Pathological Review of 18 Cases , 1988 .

[145]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[146]  J. van Nagell,et al.  The prognostic significance of lymph‐vascular space invasion in stage I endometrial cancer , 1985, Cancer.

[147]  E. Unger,et al.  Synchronous carcinomas of the uterine corpus and ovary. , 1984, Gynecologic oncology.

[148]  S. Ivarsson,et al.  Ultrasonography of the pelvic organs in prepubertal and postpubertal girls. , 1983, Archives of disease in childhood.

[149]  R. Berkowitz,et al.  45,X complete hydatidiform mole. , 1982, Gynecologic oncology.

[150]  R. Kempson,et al.  Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma , 1982, The American journal of surgical pathology.

[151]  W. Creasman,et al.  THE PROGNOSTIC VALUE OF PERITONEAL CYTOLOGY IN GYNECOLOGIC MALIGNANT DISEASE , 1972 .

[152]  W. Creasman,et al.  The prognostic value of peritoneal cytology in gynecologic malignant disease. , 1971, American journal of obstetrics and gynecology.

[153]  Langlois Pl The size of the normal uterus. , 1970 .

[154]  P. Langlois The size of the normal uterus. , 1970, The Journal of reproductive medicine.

[155]  E. Davis CARCINOMA OF THE CORPUS UTERI. , 1964, American journal of obstetrics and gynecology.